Travere Therapeutics, Inc. (TVTX)
54.73
+1.46
(+2.74%)
USD |
NASDAQ |
Oct 15, 09:51
Travere Therapeutics Total Long Term Debt (Quarterly) : 610.74M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 610.74M |
| March 31, 2026 | 321.64M |
| December 31, 2025 | 322.86M |
| September 30, 2025 | 324.02M |
| June 30, 2025 | 393.98M |
| March 31, 2025 | 395.00M |
| December 31, 2024 | 396.18M |
| September 30, 2024 | 397.14M |
| June 30, 2024 | 398.06M |
| March 31, 2024 | 398.98M |
| December 31, 2023 | 399.88M |
| September 30, 2023 | 400.70M |
| June 30, 2023 | 401.51M |
| March 31, 2023 | 402.30M |
| December 31, 2022 | 403.06M |
| September 30, 2022 | 403.38M |
| June 30, 2022 | 404.05M |
| March 31, 2022 | 404.77M |
| December 31, 2021 | 258.08M |
| September 30, 2021 | 256.20M |
| June 30, 2021 | 253.78M |
| March 31, 2021 | 249.28M |
| December 31, 2020 | 243.68M |
| September 30, 2020 | 240.57M |
| June 30, 2020 | 216.90M |
| Date | Value |
|---|---|
| March 31, 2020 | 207.41M |
| December 31, 2019 | 212.26M |
| September 30, 2019 | 210.16M |
| June 30, 2019 | 208.14M |
| March 31, 2019 | 228.90M |
| December 31, 2018 | 217.55M |
| September 30, 2018 | 192.75M |
| June 30, 2018 | 45.40M |
| March 31, 2018 | 45.24M |
| December 31, 2017 | 45.08M |
| September 30, 2017 | 44.91M |
| June 30, 2017 | 44.75M |
| March 31, 2017 | 44.58M |
| December 31, 2016 | 44.42M |
| September 30, 2016 | 44.26M |
| June 30, 2016 | 44.09M |
| March 31, 2016 | 43.93M |
| December 31, 2015 | 43.90M |
| September 30, 2015 | 43.75M |
| June 30, 2015 | 84.72M |
| March 31, 2015 | 84.24M |
| December 31, 2014 | 43.29M |
| September 30, 2014 | 83.29M |
| June 30, 2014 | 82.81M |
| March 31, 2014 | 31.28M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 752.53M |
| BioMarin Pharmaceutical, Inc. | 4.186B |
| Vertex Pharmaceuticals, Inc. | 1.978B |
| Viridian Therapeutics, Inc. | 242.16M |
| Krystal Biotech, Inc. | 7.045M |